We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protective Coating Helps Leishmania to Resist Macrophage Digestion

By Biotechdaily staff writers
Posted on 12 Aug 2003
Researchers studying the molecular mechanism that allows the leishmania parasite to survive inside macrophages, blood cells that usually destroy pathogenic microorganisms, have found that while the major surface lipophosphoglycan (LPG) is critical to the survival of the parasite, other molecules must collaborate with it.

Epidemiologists estimate that about 12 million people worldwide are infected with leishmania parasites. More...
The parasite is spread by the bite of sand flies and causes various types of cutaneous and visceral diseases.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) focused their studies on the role of LPG, which is abundantly expressed on the surface of parasite. Their paper published July 17, 2003, in the online edition of Proceedings of the National Academy of Sciences described the use of a strain of the parasite that was genetically engineered to lack the gene for LPG production.

Parasites without LPG were found to be ten times more vulnerable to attack by complement, and although parasites that lacked LPG invaded macrophages, they were quickly destroyed by oxidative mechanisms once inside the cells. On the other hand, parasites without LPG retained the ability to resist macrophage hydrolytic and proteolytic defenses.

"This study helps us better understand how these parasites are transmitted and how they establish infections,” said senior author Dr. Stephen M. Beverley, professor of molecular microbiology at Washington University. "It also could help efforts leading to the development of a vaccine to prevent this devastating disease.”




Related Links:
Washington University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.